Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Bronchiolitis Obliterans Syndrome × belumosudil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Bronchiolitis Obliterans Syndrome 1

Interventions

tofacitinib 1 obinutuzumab 1 milatuzumab 1 bosutinib 1 belumosudil 1 Surveys and Questionnaires 1 Lenalidomide 1 KD025 1 Interleukin-15 1 Dasatinib 1 Blood Specimen Collection 1 BMS-833923 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03640481 2024-12-12

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

Sanofi

Phase 2 Terminated

159 enrolled 25 charts 1 FDA

Bronchiolitis Obliterans Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡